| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Common Stock, $.01 Par Value | Award | $0 | +8,637 | +21% | $0.000000 | 49,256 | 24 Feb 2023 | Direct | F1 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | $131,244 | -446 | -0.91% | $294.27 | 48,810 | 24 Feb 2023 | Direct | F2 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | $1,091,447 | -3,709 | -7.6% | $294.27 | 45,101 | 24 Feb 2023 | Direct | F3 |
| transaction | CI | Common Stock, $.01 Par Value | Sale | $1,589,100 | -5,404 | -12% | $294.06 | 39,697 | 27 Feb 2023 | Direct | F4 |
| holding | CI | Common Stock, $.01 Par Value | 1,359 | 24 Feb 2023 | By 401(k) | F5 |
| Id | Content |
|---|---|
| F1 | The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| F2 | Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| F3 | Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| F4 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2022. |
| F5 | Represents shares acquired through ongoing participation in Cigna's 401(k) Plan. |